- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2021-006052-14.
Displaying page 1 of 1.
EudraCT Number: 2021-006052-14 | Sponsor Protocol Number: C1071007 | Start Date*: 2022-05-04 | ||||||||||||||||
Sponsor Name:PFIZER INC | ||||||||||||||||||
Full Title: A randomized, 2-arm, phase 3 study of elranatamab (PF-06863135) versus lenalidomide in patients with newly diagnosed multiple myeloma who are minimal residual disease-positive after undergoing auto... | ||||||||||||||||||
Medical condition: MULTIPLE MYELOMA | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) ES (Ongoing) DE (Ongoing) NO (Ongoing) FI (Ongoing) HU (Ongoing) BE (Ongoing) GR (Ongoing) NL (Ongoing) AT (Ongoing) CZ (Ongoing) PL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.